Skin Perfect makes its worldwide debut this month with a new line of natural health, beauty, and skin care supplements that are designed to deliver anti-aging benefits and healthy hair, skin, and nails.
The Food and Drug Administration on Wednesday announced approval for Zydelig (idelalisib) to treat patients with chronic lymphocytic leukemia, relapsed follicular B-cell non-Hodgkin lymphoma and relapsed small lymphocytic lymphoma.
Ateb, a privately held company that seeks ways to improve patient care and enhance pharmacy operations, announced that pharmacy veteran Mark Gregory, R. Ph., will join its team to assist with business development.
“You have to be willing to do what your competition is not willing to do.” That was one of the key messages from motivational speaker and Olympic speed skier Vince Poscente, which also tied into the message Steve Courtman, president of Health Mart, and Tony Willoughby, Health Mart chief pharmacist, had for attendees at Tuesday morning’s Health Mart Annual Meeting.
McKesson hosted its seventh annual RxOwnership Ownership Transfer Luncheon on Tuesday, where attendees interested in either acquiring an independent pharmacy operation, or selling one, could learn more about the programs and support available to them.
Tuesday morning’s Health Mart Annual Meeting provided franchisee members with an overview of recent investments in the franchise and McKesson’s plans to “help level the playing field” for independent pharmacies through new programs that improve patient outcomes and pharmacy efficiency, as well as more flexible and local marketing efforts.
Fresh from Tuesday morning’s Health Mart Annual Meeting at 2014 McKesson ideaShare, attendees eagerly gathered to take part in the Health Mart University Live sessions that addressed key topics for independent pharmacy success.
After speaking at the Health Mart Annual Meeting Tuesday morning, Tony Willoughby, Health Mart’s chief pharmacist, sat down with DSN to talk about how pharmacies can drive adherence and excel in today’s changing healthcare environment.
Walgreens on Tuesday announced the new Balance Rewards for healthy choices initiatives, which is aimed at helping participants modify behavior risk factors associated with the nation's most pressing public health issues.
During the Opening General Session at McKesson’s 2014 ideaShare conference, Frank Starn, SVP and COO of McKesson U.S. Pharmaceutical, and Steve Courtman, president, Health Mart, presented Milwaukee, Wis.-based Hayat Health Mart Pharmacy with the grand prize as the 2014 Pharmacy of the Year award winner.
Even before the official start of this year’s McKesson ideaShare conference, the Gaylord Palms Resort and Convention Center was buzzing with attendees eager to take advantage of the robust lineup of continuing education courses held on Sunday and Monday.
This year’s McKesson ideaShare 2014 kicked off with a bang as thousands of community pharmacy leaders flocked to Orlando, Fla., to participate in the annual event and seize the opportunities to grow in today’s changing healthcare landscape.
The Centers for Medicare and Medicaid Services’ Five-Star Quality Rating System already is impacting how pharmacies think about their patients and their medication adherence programs, noted Samuel Stolpe, director of quality strategies for the Pharmacy Quality Alliance, during a Lunch and Learn session Monday at McKesson ideaShare called “When the Stars Align: Prepare Your Pharmacy For Success.” According to Stolpe, it’s going to become a bigger influencer going forward, especially as the industry develops a pharmacy Star metric that will have a public element and certain health plans experiment with pay-for-performance models to incentivize higher Star ratings among pharmacies.
Addressing 3,000 independent pharmacy attendees representing more than 1,000 pharmacies at the McKesson ideaShare 2014, Mark Walchirk, president of McKesson’s U.S. pharmaceutical unit outlined the myriad of opportunities open to community pharmacy today, and how McKesson is investing in its independent pharmacy offerings to help those independents realize every one of those opportunities.
The Food and Drug Administration on Thursday announced the approval of Ruconest, a recombinant C1-Esterase inhibitor product for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema.